Literature DB >> 8779507

Audit of vascular surgical workload: use of data for service development.

P J Curley1, J I Spark, R C Kester, D J Scott.   

Abstract

The power of surgical audit lies in the ability to clearly record complications and to compare case mix from year to year and between centres in order to compare results. In addition, accurate data about surgical activity is vital for the development of new services. We have analysed 52 weeks of activity in a developing pure vascular surgical service and compared activity against the recommendations previously published for consultant surgical workload. During the 12-month period the mean number of admissions per week was 25.3 (95% CI, 23.43-27.29). Mean elective surgical activity was 18.2 h/week (95% CI, 16.5-19.9) and mean emergency workload 12.7 h (95% CI, 10.7-15.4). Mean intermediate equivalent value (IEV) operations per week was 37 (95% CI, 33.6-40.8) and of these 26.4 IEV (95% CI, 22.96-29.6) were complex major operations. Finally, the mean bed occupancy of vascular patients on the unit was 23.3 (95% CI, 21.15-24.97). The recommendations for surgical activity are 3.5 IEV/list. In our unit this would equate to 21 IEV/week compared with 37.2 in our practice. This data forms the basis of a powerful bid for increased consultant manpower and theatre resources. Surgical audit is time-consuming and should be consultant led, but the benefits are tangible and the data generated can be used to support bids for resource re-allocation.

Entities:  

Mesh:

Year:  1996        PMID: 8779507      PMCID: PMC2502701     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  10 in total

1.  The importance of vascular surgical audit to surgeons, patients and purchasers.

Authors:  J J Earnshaw; J K Hayward; M Horrocks; R N Baird
Journal:  Eur J Vasc Surg       Date:  1992-09

2.  Providing the ideal surgical service.

Authors:  C Collins
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

3.  Are readmissions avoidable?

Authors:  A Clarke
Journal:  BMJ       Date:  1990-11-17

4.  Recommended values for use in surgical audit and surgical workload analysis.

Authors:  C Collins
Journal:  Ann R Coll Surg Engl       Date:  1991-09       Impact factor: 1.891

5.  Measuring readmission rates.

Authors:  M Chambers; A Clarke
Journal:  BMJ       Date:  1990-11-17

6.  Caseload or workload? Scoring complexity of operative procedures as a means of analysing workload.

Authors:  S M Jones; C D Collins
Journal:  BMJ       Date:  1990-08-11

7.  Extending the use of clinical audit data: a resource planning model.

Authors:  B W Ellis; R C Rivett; H A Dudley
Journal:  BMJ       Date:  1990-07-21

8.  Early reoperation rates after arterial surgery.

Authors:  R L Ng; A H Davies; T R Magee; S Tennant; M Horrocks; R N Baird
Journal:  Eur J Vasc Surg       Date:  1994-01

9.  Comparative vascular audit using the POSSUM scoring system.

Authors:  G P Copeland; D Jones; A Wilcox; P L Harris
Journal:  Ann R Coll Surg Engl       Date:  1993-05       Impact factor: 1.891

10.  GORA: a scoring system for the quantification of risk of graft occlusion.

Authors:  G P Copeland; P Edwards; A Wilcox; P N Wake; P L Harris
Journal:  Ann R Coll Surg Engl       Date:  1994-03       Impact factor: 1.891

  10 in total
  3 in total

1.  Does the introduction of HDU reduce surgical mortality?

Authors:  J Davies; R Tamhane; C Scholefield; P Curley
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

2.  A 25-year study of emergency surgical admissions.

Authors:  W B Campbell; E J K Lee; K Van de Sijpe; J Gooding; M J Cooper
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

3.  Estimation of the capacity of emergency surgery in Konya: Nine-year multicenter study.

Authors:  Tevfik Küçükkartallar; Murat Çakır; Ahmet Tekin; Mehmet Balasar; Adil Kartal; Hande Köksal; Bülent Erengül; Emin Türk
Journal:  Ulus Cerrahi Derg       Date:  2016-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.